Furthermore, there were no significant differences between groups in all other parameters at baseline (duration of diabetes, BP, lipid parameters, urinary microalbumin/creatine ratio, number of antihyperglycemic medications, number of antihypertensive medications, insulin use, and glucose TIR) (Table 1). This evidence concerns the gene INS and diabetes mellitus.